World Congress on Thyroid Cancer 3.5
June 20 – 22, 2019
World Congress on Thyroid Cancer 4.0
July 29 – August 1, 2021
WCTC3.5 Steering Committee:
Rocco Bellatone, Co-Chair
Celestino Lombardi, Co-Chair
Gregory W. Randolph, MD
Bryan McIver, MD
Jeremy Freeman, MD
Ian J. Witterick, MD
Ashok R. Shaha, MD
Jatin P. Shah, MD
- Peter Sadow's presentations
Dr. Sadow, Director of Head and Neck Pathology at MGH, is also a subspecialist in Genitourinary and Endocrine Pathology. His first undergraduate research project (and publication) at MGH in the early 1990s involved the effects of thyroid hormone on tissue remodeling and wound repair. He pursued a combined MD/PhD program at the University of Chicago.
Dr. Sadow’s doctoral thesis utilized transgenic mouse models with altered thyroid hormone response genes in order to understand and advance our understanding of the effects of thyroid hormone on human physiology.
Trained in Anatomic Pathology at Brigham and Women’s Hospital, where he was born, Dr. Sadow’s clinical and research interests have continued in endocrine pathology, studying the proteomics and genomics of endocrine neoplasia, primarily of the thyroid & adrenal glands.
In addition, he has prominent teaching roles in the hospital, medical school, and in continuing medical education courses.